Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Registry study of Angong Niuhuang Pill for acute stroke
ChiCTR2100051118Phase 4Recruiting
- Sponsor
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Angong Niuhuang Pill in stroke, sponsored by Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoints: National Institutes of Health Stroke Scale (NIHSS) score and Modified Rankin Scale (mRS) score. Started Oct 2021; status: recruiting.
02
Drugs
Angong Niuhuang Pill
03
Conditions
stroke
Beyond the preview
Go deeper on ChiCTR2100051118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051118.